Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Rocket Pharmaceuticals Inc shares valued at $240,520 were sold by SOUTHWELL DAVID P on Apr 15 ’24. At $24.05 per share, SOUTHWELL DAVID P sold 10,000 shares. The insider’s holdings dropped to 114,784 shares worth approximately $2.7 million following the completion of this transaction.
Also, SOUTHWELL DAVID P sold 70,000 shares, netting a total of over 1,705,265 in proceeds. Following the sale of shares at $24.36 each, the insider now holds 95,160 shares.
Before that, White Mark Andrew had sold 12,532 shares from its account. In a trade valued at $308,763, the insider traded Rocket Pharmaceuticals Inc shares for $24.64 each. Upon closing the transaction, the insider’s holdings decreased to 12,532 shares, worth approximately $1.77 million.
As published in their initiating research note from Goldman on April 02, 2024, Rocket Pharmaceuticals Inc [RCKT] has been a Neutral and the price target has been revised to $39. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in late October. As of February 01, 2023, Morgan Stanley has initiated its “an Overweight” rating for RCKT. Earlier on November 08, 2022, Canaccord Genuity initiated its rating. Their recommendation was “a Buy” for RCKT stock.
Analyzing RCKT Stock Performance
During the last five days, there has been a drop of approximately -7.12%. Over the course of the year, Rocket Pharmaceuticals Inc shares have dropped approximately -21.65%. Shares of the company reached a 52-week high of $31.47 on 02/27/24 and a 52-week low of $23.32 on 04/18/24. A 50-day SMA is recorded $27.36, while a 200-day SMA reached $22.98. Nevertheless, trading volume fell to 0.55 million shares from 0.89 million shares the previous day.
Support And Resistance Levels for Rocket Pharmaceuticals Inc (RCKT)
According to the 24-hour chart, there is a support level at 23.22, which, if violated, would cause prices to drop to 22.97. In the upper region, resistance lies at 23.83. The next price resistance is at 24.19. RSI (Relative Strength Index) is 34.45 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.97, which suggests the price will decrease in the coming days. Percent R is at 95.64%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
